2005
DOI: 10.1016/j.ygyno.2005.03.004
|View full text |Cite
|
Sign up to set email alerts
|

LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
51
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 77 publications
(53 citation statements)
references
References 34 publications
2
51
0
Order By: Relevance
“…LPA promotes ovarian tumor development through increased cyclin D expression (Chappell et al, 2001). LPA also increases vascular endothelial growth factor production, which stimulates angiogenesis (So et al, 2005). In a colon cancer cell line, LPA increases the synthesis of macrophage migration inhibitory factor, which promotes tumor growth (Sun et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…LPA promotes ovarian tumor development through increased cyclin D expression (Chappell et al, 2001). LPA also increases vascular endothelial growth factor production, which stimulates angiogenesis (So et al, 2005). In a colon cancer cell line, LPA increases the synthesis of macrophage migration inhibitory factor, which promotes tumor growth (Sun et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…We and others have shown that LPA stimulates the migration and invasion of ovarian cancer cells (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22). Although most, if not all, of these studies were conducted in established ovarian cancer cell lines, we have recently conducted LPA-and S1P-induced cell migration and invasion experiments in primary EOC and nonmalignant human ovarian surface epithelial cells (11,23).…”
Section: Introductionmentioning
confidence: 99%
“…The EOC metastatic cascade consists of cellular migration, ECM degradation, proliferation, adhesion, membrane vesicle formation, invasion, and angiogenesis, which are uniquely influenced by the bioactive lipid LPA (42,43,46,47,49,50,(53)(54)(55). LPA has been proposed as a biomarker for ovarian cancer, with several studies showing that plasma levels were elevated in patients with ovarian cancer (49,56,57).…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, we evaluated the correlation of MMP-7 expression to EOC invasiveness by transfection of the MMP-7 sense and antisense gene into DOV13 cells. We further investigated whether MMP-7 secretion and activity are regulated by lysophosphatidic acid (LPA), a bioactive lipid growth factor that is found to be elevated in the plasma and malignant effusions of the majority of women with EOC (98%) and also promotes EOC metastasis (42).…”
Section: Introductionmentioning
confidence: 99%